Will the FDA accept Unicycive's NDA for Oxylanthanum Carbonate by November 3, 2024? | Binary | | | 4 months ago | |
Will the FDA set a PDUFA date for Unicycive's Oxylanthanum Carbonate by December 3, 2024? | Binary | | | 4 months ago | |
Will the FDA approve Unicycive's Oxylanthanum Carbonate by September 4, 2025? | Binary | | | 4 months ago | |
Will the FDA approve Soleno's NDA for DCCR for Prader-Willi Syndrome by December 27, 2024? | Binary | | | 4 months ago | |
Will Chimerix receive a Rare Pediatric Disease Priority Review Voucher for Dordaviprone by end of 2025? | Binary | | | 13 days ago | |
Will Chimerix's Dordaviprone receive FDA approval by September 30, 2025? | Binary | | | 13 days ago | |
Will Chimerix announce an ex-USA partnership for Dordaviprone by end of 2025? | Binary | | | 13 days ago | |
What will Zevra Therapeutics' Q4 2024 revenue from Miplyffa sales be? | Categorical | | | 3 months ago | |
Will Zevra Therapeutics' stock price increase by 20% or more by Dec 31, 2024? | Binary | | | 3 months ago | |
Will the FDA approve SpringWorks' NDA for Mirdametinib for NF1-PN by the end of 2024? | Binary | | | 4 months ago | |
Will SpringWorks Therapeutics' stock increase by at least 5% within one week after FDA decision on Mirdametinib? | Binary | | | 4 months ago | |
What will be UroGen Pharma's cash reserves by end of Q1 2025? | Categorical | | | 4 months ago | |
What will be the FDA's decision on UGN-102 by Q1 2025? | Categorical | | | 4 months ago | |
Will UroGen Pharma's stock price increase by 20% by end of Q1 2025? | Binary | | | 4 months ago | |
What will be the outcome of Dordaviprone's Phase 3 trial by September 30, 2025? | Categorical | | | 13 days ago | |
What will be the FDA's decision on Dordaviprone's NDA by September 30, 2025? | Categorical | | | 13 days ago | |
What will be Chimerix's market cap after FDA decision on Dordaviprone by October 31, 2025? | Categorical | | | 13 days ago | |
How many countries will approve Miplyffa for Niemann-Pick disease type C treatment by Dec 31, 2024? | Categorical | | | 3 months ago | |
Will Miplyffa be prescribed to more than 500 patients in the US by Dec 31, 2024? | Binary | | | 3 months ago | |
Will Zevra Therapeutics receive a Priority Review Voucher by Dec 31, 2024? | Binary | | | 3 months ago | |
What will be Miplyffa's market share in the Niemann-Pick disease type C treatment market by Dec 31, 2024? | Categorical | | | 3 months ago | |
What will be the FDA's decision on Unicycive's Oxylanthanum Carbonate by September 4, 2025? | Categorical | | | 4 months ago | |
When will the FDA set a PDUFA date for Unicycive's Oxylanthanum Carbonate by December 3, 2024? | Categorical | | | 4 months ago | |
What will be the FDA's decision on Unicycive's NDA for Oxylanthanum Carbonate by November 3, 2024? | Categorical | | | 4 months ago | |
How will Soleno Therapeutics' stock react within one week after FDA decision on DCCR? | Categorical | | | 4 months ago | |
What will be the outcome of the FDA AdComm meeting on Soleno's NDA for DCCR by December 27, 2024? | Categorical | | | 4 months ago | |
How will SpringWorks Therapeutics' stock react within one week after FDA decision on Mirdametinib? | Categorical | | | 4 months ago | |
What will be UroGen Pharma's net product revenue from JELMYTO® by end of Q1 2025? | Categorical | | | 4 months ago | |
